VRPXVirpax Pharmaceuticals, Inc.

Nasdaq virpaxpharma.com


$ 0.79 $ -1.51 (-65.94 %)    

Wednesday, 15-May-2024 15:35:01 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 0.78
$ 1.12
$ 0.00 x 0
$ 0.00 x 0
$ 0.69 - $ 1.12
$ 0.68 - $ 11.77
2,653,778
na
913,562
$ 0.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 12-07-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-22-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 virpax-announces-pricing-of-225m-public-offering

Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing n...

 virpax-pharmaceuticals-announced-results-for-a-maximum-tolerated-dose-study-in-sprague-dawley-rats-for-probudur

Probudur is Virpax's injectable long-acting liposomal bupivacaine formulation that is injected at the wound site. Probudur ...

 on-april-2-virpax-pharmaceuticals-inc-got-letter-from-nasdaq-stating-that-company-was-not-in-compliance-with-nasdaq-listing-rule

- SEC Filing

Core News & Articles

As part of the settlement, the parties have agreed to a cash payment from Virpax to the Plaintiffs of $3.5 million by March 1, ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION